Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Grant/Award of 57,482 AGMB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | AgomAb Therapeutics NV (AGMB) | Grant/Award | 57,482 | n/a |
| Aug 7, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 40,000 | $337.6K |
| Mar 17, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 59,700 | $400.0K |
| Mar 14, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 122,918 | $823.6K |
| Feb 4, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 355,000 | n/a |
| Oct 3, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 120,000 | n/a |
| Feb 4, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 340,000 | n/a |
| May 29, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 243,000 | n/a |
| Jan 26, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 275,000 | n/a |